TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9616817

Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization at 5 mg (A5)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Salbutamol nebulization at 5 mg (S)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization at 2 mg (A2)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Epinephrine nebulization (A5)
Number of subjects: 13
Study: 1356117

Group type: EXPERIMENTAL
Intervention: Budesonide (0.4 mg at 8 AM and 8 PM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bambuterol (20 mg at 8 PM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3935372

Group type: EXPERIMENTAL
Intervention: NORPLANT (six capsules)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covered rods (six rods)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31517134

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study: 29124773

Group type: EXPERIMENTAL
Intervention: Orange beverage (OB)
Number of subjects: 30
Study: 27123784

Group type: EXPERIMENTAL
Intervention: Atorvastatin plus Metformin (20 mg atorvastatin daily plus 500 mg metformin twice daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (20 mg atorvastatin daily)
Number of subjects: 130
Study: 24856229

Group type: EXPERIMENTAL
Intervention: Pressure support (PS) 20 cm H2O + PEEP 0 cm H2O (setting-1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pressure support (PS) 15 cm H2O + PEEP 5 cm H2O (setting-2)
Number of subjects: 8
Study: 21918802

Group type: EXPERIMENTAL
Intervention: Alumina ceramic bearings (144 hips)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Metal-on-polyethylene bearings (72 hips)
Number of subjects: 189
Study: 20649686

Group type: EXPERIMENTAL
Intervention: Structured, patient-centered interview conducted by trained health professionals.
Number of subjects: 313

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 313
Study: 18725614

Group type: EXPERIMENTAL
Intervention: Discontinuation of oral anticoagulant therapy after 6 months
Number of subjects: 600

Group type: COMPARATOR
Intervention: Oral anticoagulant therapy (5-7 months after initiation)
Number of subjects: 600
Study: 15920039

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Current therapy (two or three shots per day using NPH insulin and rapid-acting analog)
Number of subjects: 26
Study: 12885745

Group type: EXPERIMENTAL
Intervention: Simvastatin (5 mg/d increased to 10 mg/d after 4 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 63
Study: 10561302

Group type: EXPERIMENTAL
Intervention: Short interval (SI) group: surgery within 2 weeks after completion of radiation therapy
Number of subjects: 201

Group type: COMPARATOR
Intervention: Long interval (LI) group: surgery 6 to 8 weeks after completion of radiation therapy
Number of subjects: 201
Study: 7995909

Group type: EXPERIMENTAL
Intervention: Gore-Tex sling treatment (alone or in combination with prolapsus cure)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Gore-Tex sling treatment
Number of subjects: 72
Study: 2646849

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 19

Group type: COMPARATOR
Intervention: Gallamine
Number of subjects: 19
Study: 5394178

Group type: COMPARATOR
Intervention: Traditional intermenstrual insertion
Number of subjects: 1486

Group type: EXPERIMENTAL
Intervention: Post-abortion insertion
Number of subjects: 1486

Group type: EXPERIMENTAL
Intervention: Postpartum insertion
Number of subjects: 1486
Study: 31090348

Group type: EXPERIMENTAL
Intervention: P-PRP (2.5 mL injected at the bone graft site)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: L-PRP (2.5 mL injected at the bone graft site)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: P-PRP
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: L-PRP
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 28341018

Group type: EXPERIMENTAL
Intervention: Shaping Healthy Choices Program (SHCP)
Number of subjects: 30
Study: 24635370

Group type: EXPERIMENTAL
Intervention: Total Abdominal Hysterectomy from Infraumbilical Median Laparotomy (AHL)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Abdominal Hysterectomy from Suprapubic Transverse Incision (AH)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy with Colpectomy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Postoperative complications in AH group
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Postoperative complications in TLH group
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: AHL and LAVH complications
Number of subjects: 163
Study: 22920051

Group type: EXPERIMENTAL
Intervention: Home at Hospital (HaH) care
Number of subjects: 9

Group type: COMPARATOR
Intervention: Traditional hospital care
Number of subjects: 9
Study: 19918197

Group type: EXPERIMENTAL
Intervention: Dorsiflexion (DF) shoes
Number of subjects: 21
Study: 18191149

Group type: EXPERIMENTAL
Intervention: Ataxia Functional Composite Scale (AFCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Buspirone
Number of subjects: 0
Study: 15653650

Group type: EXPERIMENTAL
Intervention: Bone-seeking radiopharmaceuticals
Number of subjects: 0
Study: 12535753

Group type: EXPERIMENTAL
Intervention: Fenofibrate intervention (not specified dosage or duration)
Number of subjects: 134
Study: 10433131

Group type: EXPERIMENTAL
Intervention: Combined psychoeducational and cognitive treatment including key-person counselling
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 191
Study: 8688757

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg or 40 mg daily
Number of subjects: 621

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 621
Study: 1424414

Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg per day)
Number of subjects: 0
Study: 2870547

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (100 mg per day in two doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30184181

Group type: EXPERIMENTAL
Intervention: TOL-463 vaginal insert
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: TOL-463 vaginal gel
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: TOL-463 (both forms)
Number of subjects: 106
Study: 28183146

Group type: EXPERIMENTAL
Intervention: Prenatal ultrasound monitoring, interdisciplinary team approach, planned delivery through cesarean section, postnatal coverage of the intestine with a silastic bag, first intervention within the first 6 hours after birth, attempt of primary abdominal wall closure, perioperative antibiotic treatment.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fetal therapy, preterm delivery, lack of abdominal pressure monitoring.
Number of subjects: 89
Study: 27876742

Group type: EXPERIMENTAL
Intervention: Neuromidin therapy (1.5 month-long course) in addition to standard treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment without Neuromidin
Number of subjects: 50
Study: 25146127

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23181667

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (within 72 hours after randomization)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Interval laparoscopic cholecystectomy (25 to 30 days after randomization)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Interval laparoscopic cholecystectomy
Number of subjects: 266
Study: 20102891

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 5745
Study: 17016799

Group type: EXPERIMENTAL
Intervention: Urodynamic investigation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Perineal ultrasound
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Correlation between urodynamics and perineal ultrasound
Number of subjects: 66
Study: 15863535

Group type: EXPERIMENTAL
Intervention: Brief intervention including partner participation
Number of subjects: 304

Group type: COMPARATOR
Intervention: Brief intervention without partner participation
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Partner participation in brief intervention
Number of subjects: 304
Study: 12177686

Group type: COMPARATOR
Intervention: Galantamine 16 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Galantamine 24 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Galantamine 24 mg/day for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Galantamine (both dosages)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Galantamine
Number of subjects: 0
Study: 10445961

Group type: EXPERIMENTAL
Intervention: Telephone SCID for major depression
Number of subjects: 41

Group type: COMPARATOR
Intervention: In-person SCID for major depression
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Telephone SCID for simple phobia
Number of subjects: 41

Group type: COMPARATOR
Intervention: In-person SCID for simple phobia
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Telephone SCID for social phobia
Number of subjects: 41

Group type: COMPARATOR
Intervention: In-person SCID for social phobia
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Overall agreement for specific lifetime diagnoses
Number of subjects: 41
Study: 7549892

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte‐macrophage colony‐stimulating factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony‐stimulating factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth factor mobilized peripheral blood stem cells
Number of subjects: 0
Study: 2012294

Group type: EXPERIMENTAL
Intervention: Caudal block
Number of subjects: 54

Group type: COMPARATOR
Intervention: Local wound infiltration
Number of subjects: 54
Study: 7059442

Group type: EXPERIMENTAL
Intervention: Lofexidine 0.1 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lofexidine 0.3 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lofexidine 0.6 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lofexidine (mean threshold dose)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lofexidine
Number of subjects: 19
Study: 30985996

Group type: EXPERIMENTAL
Intervention: 1975 Japanese diet (JD)
Number of subjects: 60
Study: 28629250

Group type: EXPERIMENTAL
Intervention: Ginger (500 mg twice daily)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Vitamin B6 (40 mg twice daily)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 77
Study: 26684319

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (no zinc supplementation)
Number of subjects: 96
Study: 25043221

Group type: EXPERIMENTAL
Intervention: Mandolean training (intervention)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both arms (intervention and control)
Number of subjects: 21
Study: 23074203

Group type: EXPERIMENTAL
Intervention: Contact Lens (CL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraocular Lens (IOL)
Number of subjects: 0
Study: 18804877

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 123

Group type: COMPARATOR
Intervention: Bare metal stents (control)
Number of subjects: 123
Study: 18298032

Group type: EXPERIMENTAL
Intervention: 6 month individualised exercise programme using a purpose built dialysis exercise machine
Number of subjects: 22
Study: 15665015

Group type: EXPERIMENTAL
Intervention: Baseline AMH serum concentrations
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Day 5 AMH serum concentrations
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Day 5 AMH
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Day 5 estradiol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Basal AMH and day 5 AMH or estradiol measurements
Number of subjects: 80
Study: 11827510

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11258740

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual community services
Number of subjects: 118
Study: 8829791

Group type: EXPERIMENTAL
Intervention: Allowances and forgivable loans to raise them above the poverty line for one year.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Some funds, but not enough to raise them above the poverty line.
Number of subjects: 54
Study: 2081722

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg or 1000 mg bd)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard therapy (rifampicin plus doxycycline)
Number of subjects: 6
Study: 370367

Group type: EXPERIMENTAL
Intervention: Sodium acetylo-salicylate (2 g per os) during heat exposure at 37 degrees C
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium acetylo-salicylate (2 g per os) during exercise at 25 degrees C
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo during heat exposure at 37 degrees C
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo during exercise at 25 degrees C
Number of subjects: 10
Study: 31696741

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 60
Study: 28969434

Group type: EXPERIMENTAL
Intervention: Increasing stretch velocity method
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decreasing stretch velocity method
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Randomised stretch velocity method
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tonic stretch reflex threshold (TSRT) measurement
Number of subjects: 10
Study: 28930959

Group type: EXPERIMENTAL
Intervention: TBI + HS
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: TBI
Number of subjects: 670

Group type: COMPARATOR
Intervention: HS
Number of subjects: 670

Group type: COMPARATOR
Intervention: Neither group
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: TBI + HS and TBI
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: TBI + HS or TBI
Number of subjects: 670
Study: 25864611

Group type: EXPERIMENTAL
Intervention: 25(OH)D concentrations
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Control group (better educated participants)
Number of subjects: 1009
Study: 23219660

Group type: EXPERIMENTAL
Intervention: Bevacizumab (Arm 3)
Number of subjects: 1693

Group type: EXPERIMENTAL
Intervention: Bevacizumab in cycles 2-6 only (Arm 2)
Number of subjects: 1693

Group type: COMPARATOR
Intervention: Chemotherapy alone (Arm 1)
Number of subjects: 1693
Study: 21965475

Group type: EXPERIMENTAL
Intervention: High-dose epirubicin plus cyclophosphamide (EC) - E 120 mg/m², C 600 mg/m² for four cycles every 21 days
Number of subjects: 750

Group type: COMPARATOR
Intervention: Docetaxel (D) 100 mg/m² followed by four cycles of EC for four cycles every 21 days
Number of subjects: 750
Study: 19244153

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Nutrition supplementation
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 17328643

Group type: EXPERIMENTAL
Intervention: Presurgical orthopedics (PSO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No presurgical orthopedics (No PSO)
Number of subjects: 50
Study: 15117298

Group type: EXPERIMENTAL
Intervention: 2RE(3)HZ(3)(alt)/4RH(2) (split I)
Number of subjects: 1240

Group type: EXPERIMENTAL
Intervention: 3RE(3)HZ(3)(alt)/3RH(2) (split II)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: 2REHZ(3)/4RH(2) (control)
Number of subjects: 1240
Study: 11846927

Group type: EXPERIMENTAL
Intervention: Postoperative external beam radiation therapy
Number of subjects: 301
Study: 9751087

Group type: EXPERIMENTAL
Intervention: cA2 at 3 or 10 mg/kg with or without MTX
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg without MTX
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg with MTX
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo plus low-dose MTX
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: cA2 at 10 mg/kg with MTX
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: cA2 at 1 mg/kg alone
Number of subjects: 101
Study: 8176574

Group type: EXPERIMENTAL
Intervention: Clarithromycin suspension at 3.75, 7.5, and 15 mg/kg per dose every 12 hours
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Clarithromycin suspension at 15 mg/kg per dose every 12 hours
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Clarithromycin suspension
Number of subjects: 25
Study: 3653081

Group type: EXPERIMENTAL
Intervention: Fentanyl 1, 2 or 3 micrograms kg‐1 in adults
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 or 2 micrograms kg‐1 in children
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no pretreatment) in adults
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no pretreatment) in children
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Fentanyl (any dose)
Number of subjects: 190
Study: 28843973

Group type: EXPERIMENTAL
Intervention: Carrot soup with MSG (5 g, 1% w/w)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Whey protein enriched carrot soup with MSG (5 g, 1% w/w)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Carrot soup with MSG and protein
Number of subjects: 43

Group type: COMPARATOR
Intervention: Carrot soup with no additions
Number of subjects: 43
Study: 26961571

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Ethacrynic acid
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cross-clamp time
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Blood pH at the end of POD0
Number of subjects: 67
Study: 25104273

Group type: EXPERIMENTAL
Intervention: eicosapentaenoic acid-docosahexaenoic acid
Number of subjects: 2344

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2344

Group type: EXPERIMENTAL
Intervention: α-linolenic acid
Number of subjects: 2344

Group type: EXPERIMENTAL
Intervention: eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid
Number of subjects: 2344
Study: 22808789

Group type: EXPERIMENTAL
Intervention: Enteral nutritive mixtures with branched-chain amino acids (BCAA)
Number of subjects: 0
Study: 20174466

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) alone
Number of subjects: 315

Group type: COMPARATOR
Intervention: NSAIDs plus ASA
Number of subjects: 315
Study: 17851077

Group type: EXPERIMENTAL
Intervention: Concomitant tumour bed boost (CB) with whole breast radiotherapy (RT) delivering 50Gy and an electron boost of 12.5Gy in 5 weekly fractions.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CRT) with tumour bed boost of 15Gy in 6 fractions delivered after whole breast irradiation.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Concomitant tumour bed boost (CB) with whole breast RT compared to CRT.
Number of subjects: 30
Study: 16375760

Group type: EXPERIMENTAL
Intervention: Walking Program (WP) and Vitamin Supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walking Program (WP) and Placebo Supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo Activity Program (PAP) and Vitamin Supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo Activity Program (PAP) and Placebo Supplements
Number of subjects: 0
Study: 12452877

Group type: EXPERIMENTAL
Intervention: Oral antifungal agents
Number of subjects: 496
Study: 10632026

Group type: EXPERIMENTAL
Intervention: 2% chloroprocaine (20 microl)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (20 microl)
Number of subjects: 10
Study: 7769406

Group type: EXPERIMENTAL
Intervention: Plasma fibrinogen levels
Number of subjects: 6457

Group type: EXPERIMENTAL
Intervention: Multivariable linear regression analysis
Number of subjects: 6457
Study: 2022788

Group type: EXPERIMENTAL
Intervention: In-office bleaching technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no bleaching)
Number of subjects: 20
Study: 6114845

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (2 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Etilefrine (20 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined treatment (2 mg dihydroergotamine and 20 mg etilefrine)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 31025365

Group type: EXPERIMENTAL
Intervention: Platform-Switching (PS) components
Number of subjects: 68

Group type: COMPARATOR
Intervention: Platform-Matching (PM) components
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (PS and PM)
Number of subjects: 68
Study: 29358870

Group type: EXPERIMENTAL
Intervention: Study regimen (oral sulfate solution 89 mL with diatrizoate solution: boost 1 = 60 mL, boost 2 = 30 mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control regimen (oral sulfate solution 89 mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 0
Study: 25605861

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus trastuzumab (arms B and C)
Number of subjects: 1282

Group type: COMPARATOR
Intervention: Chemotherapy alone (arm A)
Number of subjects: 1282
Study: 24854634

Group type: EXPERIMENTAL
Intervention: Anodal bilateral primary somatosensory areas transcranial direct current stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 22961225

Group type: EXPERIMENTAL
Intervention: Short-term high-fat overfeeding (HFO) diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 21
Study: 19399720

Group type: EXPERIMENTAL
Intervention: GnRH antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: LHRH agonists
Number of subjects: 0